STOCK TITAN

Ventas Stock Price, News & Analysis

VTR NYSE

Welcome to our dedicated page for Ventas news (Ticker: VTR), a resource for investors and traders seeking the latest updates and insights on Ventas stock.

News and updates about Ventas, Inc. (NYSE: VTR) focus on its activities as a healthcare-focused S&P 500 real estate investment trust. The company regularly issues press releases on quarterly earnings, senior housing performance, capital markets activity and corporate developments, providing investors and observers with insight into its large portfolio of approximately 1,400 properties in North America and the United Kingdom.

Ventas’s news flow frequently highlights results for its senior housing operating portfolio, which the company identifies as a major driver of growth. Earnings releases have discussed year-over-year growth in net operating income, occupancy trends and margin expansion in senior housing, as well as the impact of its Ventas OI™ data platform on operating performance. These communications also describe senior housing acquisitions and investment volumes, reflecting the company’s focus on expanding this part of its business.

Another recurring theme in Ventas news is capital and financing activity. Recent announcements have covered the pricing and issuance of senior notes through its subsidiary Ventas Realty, Limited Partnership, and amendments to unsecured term loan facilities guaranteed by Ventas, Inc. The company also provides information on its liquidity position, use of equity forward sales agreements and credit arrangements in its earnings-related materials.

Corporate governance and leadership updates appear in the news as well, such as the planned retirement of senior executives and related transition plans. Ventas also issues notices about participation in investor conferences and the availability of presentation materials on its investor relations site.

Dividend declarations are another regular topic, with press releases detailing quarterly cash dividends on common shares and the associated record and payment dates. Together, these categories of news give a detailed picture of Ventas’s operating performance, investment activity, balance sheet management and corporate priorities. Investors following VTR news can monitor these updates to understand how the company is managing its healthcare and senior housing real estate portfolio over time.

Rhea-AI Summary

Ventas, Inc. (NYSE: VTR) has declared a quarterly dividend of $0.45 per common share, payable on January 19, 2023, to shareholders recorded by the close of business on January 3, 2023. Ventas operates over 1,200 properties across the U.S., Canada, and the U.K., focusing on healthcare real estate driven by demographic demand. With over 20 years of a successful, diversified strategy, Ventas emphasizes financial strength, reliable growth, and significant ESG achievements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.01%
Tags
dividends earnings
-
Rhea-AI Summary

Ardent Health Services and BioIntelliSense have launched a continuous patient monitoring initiative using BioIntelliSense’s BioButton wearable devices to enhance clinical workflow. With implementation starting at BSA Hospital in Amarillo, Texas, the program collects vital signs up to 1,440 times daily, compared to traditional methods that collect data only 4-6 times. The initiative aims to reduce hospital stays and improve patient outcomes. The partnership employs advanced analytics integrated with Ardent’s Epic electronic health records for effective patient monitoring.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.76%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.66%
Tags
none
Rhea-AI Summary

Ventas, Inc. (NYSE: VTR) announced its participation in investor meetings at Nareit’s REITworld 2022 Annual Conference on November 15-16, 2022. Accompanying materials will be available on the Company’s website around November 14, 2022, and archived for a limited time thereafter.

Ventas is an S&P 500 company operating in healthcare and real estate, with over 1,200 properties across the U.S., Canada, and the UK. The Company focuses on senior living, life sciences, and healthcare real estate, backed by a 20-year successful diversification strategy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.19%
Tags
conferences
-
Rhea-AI Summary

Ventas (NYSE: VTR) reported its Q3 2022 financial results, revealing a net income attributable to common stockholders of $0.00 per share, while Normalized FFO was $0.76, benefiting from $20 million in HHS grants. The company's same-store cash Net Operating Income (NOI) grew 4.8%, with the Senior Housing Operating Portfolio (SHOP) segment seeing a significant 13% increase. Ventas anticipates Q4 growth in SHOP cash NOI ranging from 15% to 21%, despite challenges from rising interest rates. The company maintains a strong balance sheet with $2.5 billion in liquidity and favorable debt maturity profiles.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.73%
Tags
-
Rhea-AI Summary

Ventas, Inc. (NYSE: VTR) will release its third quarter 2022 earnings on November 3, 2022, after the market closes. A conference call to discuss these results is scheduled for November 4, 2022, at 10:00 a.m. ET. Investors can participate via a dial-in number or through a live webcast available on www.ventasreit.com. Ventas operates over 1,200 properties across the U.S., Canada, and the U.K., focusing on healthcare and real estate sectors driven by the growing aging population.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.86%
Tags
conferences earnings
Rhea-AI Summary

Ardent Health Services has appointed Carlene Callis as chief system integration and growth officer and Ben Jacobs as chief strategy and development officer. Callis will enhance care delivery and operational efficiency across the organization. With over 25 years in healthcare, she previously served at HCA. Jacobs, with nearly two decades of experience, will focus on strategic planning and expansion into new markets. Both leaders aim to strengthen Ardent’s mission of improving community healthcare access.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.42%
Tags
management
-
Rhea-AI Summary

Ventas, Inc. (NYSE: VTR) announced its participation in investor meetings at the Mizuho Healthcare REIT Conference on October 4, 2022. Written materials for the event will be available on the Company's website around the same date, and these will be archived for a limited time.

Ventas operates over 1,200 properties across the United States, Canada, and the United Kingdom, focusing on healthcare and real estate. The company’s strategy emphasizes diversification and financial strength, aimed at unlocking value in senior living and healthcare real estate.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.59%
Tags
conferences
-
Rhea-AI Summary

Ventas, Inc. (NYSE: VTR) has declared a quarterly dividend of $0.45 per share, payable on October 14, 2022, to stockholders recorded by the close of business on October 3, 2022.

As a leading real estate investment trust, Ventas operates in healthcare and real estate sectors with a portfolio of over 1,200 properties across the United States, Canada, and the United Kingdom. The company leverages its capital to enhance senior living, life science, and healthcare real estate.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.39%
Tags
dividends earnings
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.91%
Tags
none

FAQ

What is the current stock price of Ventas (VTR)?

The current stock price of Ventas (VTR) is $86.66 as of March 2, 2026.

What is the market cap of Ventas (VTR)?

The market cap of Ventas (VTR) is approximately 40.9B.

VTR Rankings

VTR Stock Data

40.92B
472.40M
REIT - Healthcare Facilities
Real Estate Investment Trusts
Link
United States
CHICAGO

VTR RSS Feed